IN-DEPTH: DERMATOLOGY AND LUMPOLOGY
It is also important to know that in some cases, application of remedies of various natural and homeopathic types have resulted in considerable exacerbation of the tumors. This is probably more a property of the fact that the tumors have been interfered with rather than any directly harmful effect of the so-called remedy.
Prognosis
The prognosis is always very guarded and owners should be made aware of the possible serious com- plications, which can arise both from the disease itself and from the treatment. A diagnosis of equine sarcoid has a very serious effect on the value of the horse and the likely enjoyment that the owner will get out of it.
Summary
Whatever is said about the equine sarcoid in folk- lore and in the largely ill-informed lay press, it should undoubtedly be regarded as a form of skin cancer. It should therefore be treated with the re- spect deserving of any neoplastic state; early veter- inary consultation will help to ensure that the condition is held in check and not allowed to run rampant through the skin of a horse. Whenever a horse is found to have a sarcoid lesion, it needs to be put into the proper perspective. The condition is unpredictable and before a buyer purchases a horse they should be sure of the insurance implications and the likelihood that treatment will be required. A single small lesion may remain identical until the horse dies of old age but it could erupt at any time or it may herald the development of more lesions as time passes; the difficulty is deciding which is which. There is no clinical indicator which helps to predict which lesions will take on an aggressive form and which will not. It is clear that the fewer lesions that are present at any one time, the fewer it will get and this may link to the feeding habits of flies during summer months. Horses should be as sarcoid free as they can be over the summer months when flies are a problem. The condition is more related to surface feeding flies than to blood feeding flies since the latter do not ever visit open ulcerated sites. The prospects for successful treatment are far bet-
ter if the lesions are small, early, and the horse is under 4–5 years of age. None of the treatment methods are cheap and none of them are certain of success. Sarcoids around the face and on the legs are particularly dangerous in almost every aspect of the disease and owners should not be unduly sur- prised when any selected treatment fails to help, in fact the treatment could make matters worse. Fur- thermore, there is no current method for treating microscopic lesions—treatment is only possible for lesions that are visible. It is hoped that eventually there will be a way to make the immune processes of the patient recognize the presence of abnormal cells and reject them—this way every single cell could be detected and destroyed; there would be no
more sarcoids. This is some way off yet—if it were as simple as this there would be an answer to every cancer and disease in every species of animal. There is a desperate need for more effec- tive treatments and some form of prophylaxis if this disease is going to be eliminated from the horse population to avoid the welfare and cost implications. The correct choice of treatment method is critical.
The best possible method should be used for each individual lesion taking into account the type, ana- tomical location, duration, and previous treatment history, and owners’ resources. Each factor will in- fluence the decision but no method is universally effective. Resorting to homeopathic irrationality or other inappropriate interference is not what cancer deserves. Unless and until there is a wider appre- ciation of what the disease is and how it can develop into an irretrievable situation, horses will continue to be destroyed. There is no doubt that many sarcoid lesions can be treated by one means or another. As always, the successes are not the problem—it’s the failures. Failure of any treatment has to be viewed as a potential disaster since the prognosis for subsequent treatments falls dramatically (by around 40%). Any claims for 100% effective treatment should be viewed with considerable skepticism: either the cases are so carefully selected or the results are interpreted constructively. There is nothing more expensive than a cheap treat-
ment that does not work except of course an expensive treatment that does not work. A lack of research effort in equine oncology is possibly the most signifi- cant single factor that constrains oncologic advances. In spite of the ease of access and diagnosis, cutaneous oncology still receives little research effort or clinical interest.
Acknowledgments
Declaration of Ethics The Author has adhered to the Principles of Veteri- nary Medical Ethics of the AVMA.
Conflict of Interest The Author has no conflicts of interest.
References and Footnotes
1. Haspeslagh M, Vlaminck L, Martens A. The possible role of Stomoxys calcitrans in equine sarcoid transmission. Vet J 2018;231:8–12.
2. Jackson C. The incidence and pathology of tumours of do- mestic animals in South Africa: A study of the Onderstepoort collection of neoplasms with special reference to their histo- pathology Onderstepoort. J Vet Res 1936;6:1–9.
3. Knottenbelt DC. A clinical classification of the equine sar- coid. Clin Tech Equine Pract 2005;4:278–295.
4. Knottenbelt DC, Kelly DF. The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974–1999. Vet Ophthalmol 2000;3:73–82
5. Knottenbelt DC. A suggested clinical classification for the equine sarcoid. Clin Tech Equine Pract 2006;4:278–295.
AAEP PROCEEDINGS Vol. 65 2019 19
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197 |
Page 198 |
Page 199 |
Page 200 |
Page 201 |
Page 202 |
Page 203 |
Page 204 |
Page 205 |
Page 206 |
Page 207 |
Page 208 |
Page 209 |
Page 210 |
Page 211 |
Page 212 |
Page 213 |
Page 214 |
Page 215 |
Page 216 |
Page 217 |
Page 218 |
Page 219 |
Page 220 |
Page 221 |
Page 222 |
Page 223 |
Page 224 |
Page 225 |
Page 226 |
Page 227 |
Page 228 |
Page 229 |
Page 230 |
Page 231 |
Page 232 |
Page 233 |
Page 234 |
Page 235 |
Page 236 |
Page 237 |
Page 238 |
Page 239 |
Page 240 |
Page 241 |
Page 242 |
Page 243 |
Page 244 |
Page 245 |
Page 246 |
Page 247 |
Page 248 |
Page 249 |
Page 250 |
Page 251 |
Page 252 |
Page 253 |
Page 254 |
Page 255 |
Page 256 |
Page 257 |
Page 258 |
Page 259 |
Page 260 |
Page 261 |
Page 262 |
Page 263 |
Page 264 |
Page 265 |
Page 266 |
Page 267 |
Page 268 |
Page 269 |
Page 270 |
Page 271 |
Page 272 |
Page 273 |
Page 274 |
Page 275 |
Page 276 |
Page 277 |
Page 278 |
Page 279 |
Page 280 |
Page 281 |
Page 282 |
Page 283 |
Page 284 |
Page 285 |
Page 286 |
Page 287 |
Page 288 |
Page 289 |
Page 290 |
Page 291 |
Page 292 |
Page 293 |
Page 294 |
Page 295 |
Page 296 |
Page 297 |
Page 298 |
Page 299 |
Page 300 |
Page 301 |
Page 302 |
Page 303 |
Page 304 |
Page 305 |
Page 306 |
Page 307 |
Page 308 |
Page 309 |
Page 310 |
Page 311 |
Page 312 |
Page 313 |
Page 314 |
Page 315 |
Page 316 |
Page 317 |
Page 318 |
Page 319 |
Page 320 |
Page 321 |
Page 322 |
Page 323 |
Page 324 |
Page 325 |
Page 326 |
Page 327 |
Page 328 |
Page 329 |
Page 330 |
Page 331 |
Page 332 |
Page 333 |
Page 334 |
Page 335 |
Page 336 |
Page 337 |
Page 338 |
Page 339 |
Page 340 |
Page 341 |
Page 342 |
Page 343 |
Page 344 |
Page 345 |
Page 346 |
Page 347 |
Page 348 |
Page 349 |
Page 350 |
Page 351 |
Page 352 |
Page 353 |
Page 354 |
Page 355 |
Page 356 |
Page 357 |
Page 358 |
Page 359 |
Page 360 |
Page 361 |
Page 362 |
Page 363 |
Page 364 |
Page 365 |
Page 366 |
Page 367 |
Page 368 |
Page 369 |
Page 370 |
Page 371 |
Page 372 |
Page 373 |
Page 374 |
Page 375 |
Page 376 |
Page 377 |
Page 378 |
Page 379 |
Page 380 |
Page 381 |
Page 382 |
Page 383 |
Page 384 |
Page 385 |
Page 386 |
Page 387 |
Page 388 |
Page 389 |
Page 390 |
Page 391 |
Page 392 |
Page 393 |
Page 394 |
Page 395 |
Page 396 |
Page 397 |
Page 398 |
Page 399 |
Page 400 |
Page 401 |
Page 402 |
Page 403 |
Page 404 |
Page 405 |
Page 406 |
Page 407 |
Page 408 |
Page 409 |
Page 410 |
Page 411 |
Page 412 |
Page 413 |
Page 414 |
Page 415 |
Page 416 |
Page 417 |
Page 418 |
Page 419 |
Page 420 |
Page 421 |
Page 422 |
Page 423 |
Page 424 |
Page 425 |
Page 426 |
Page 427 |
Page 428 |
Page 429 |
Page 430 |
Page 431 |
Page 432 |
Page 433 |
Page 434 |
Page 435 |
Page 436 |
Page 437 |
Page 438 |
Page 439 |
Page 440 |
Page 441 |
Page 442 |
Page 443 |
Page 444 |
Page 445 |
Page 446 |
Page 447 |
Page 448 |
Page 449 |
Page 450 |
Page 451 |
Page 452 |
Page 453 |
Page 454 |
Page 455 |
Page 456 |
Page 457 |
Page 458 |
Page 459 |
Page 460 |
Page 461 |
Page 462 |
Page 463 |
Page 464 |
Page 465 |
Page 466 |
Page 467 |
Page 468 |
Page 469 |
Page 470 |
Page 471 |
Page 472 |
Page 473 |
Page 474 |
Page 475 |
Page 476 |
Page 477 |
Page 478 |
Page 479 |
Page 480 |
Page 481 |
Page 482 |
Page 483 |
Page 484 |
Page 485 |
Page 486 |
Page 487 |
Page 488 |
Page 489 |
Page 490 |
Page 491 |
Page 492 |
Page 493 |
Page 494 |
Page 495 |
Page 496 |
Page 497 |
Page 498 |
Page 499 |
Page 500 |
Page 501 |
Page 502 |
Page 503 |
Page 504 |
Page 505 |
Page 506 |
Page 507 |
Page 508 |
Page 509 |
Page 510 |
Page 511 |
Page 512 |
Page 513 |
Page 514 |
Page 515 |
Page 516 |
Page 517 |
Page 518 |
Page 519 |
Page 520 |
Page 521 |
Page 522 |
Page 523 |
Page 524 |
Page 525 |
Page 526 |
Page 527 |
Page 528 |
Page 529 |
Page 530 |
Page 531 |
Page 532 |
Page 533 |
Page 534 |
Page 535 |
Page 536 |
Page 537 |
Page 538 |
Page 539 |
Page 540 |
Page 541 |
Page 542 |
Page 543 |
Page 544 |
Page 545 |
Page 546 |
Page 547 |
Page 548 |
Page 549 |
Page 550 |
Page 551 |
Page 552 |
Page 553 |
Page 554 |
Page 555 |
Page 556 |
Page 557 |
Page 558 |
Page 559 |
Page 560 |
Page 561 |
Page 562 |
Page 563 |
Page 564 |
Page 565 |
Page 566 |
Page 567 |
Page 568 |
Page 569 |
Page 570 |
Page 571 |
Page 572 |
Page 573 |
Page 574 |
Page 575 |
Page 576